Title |
Mig-6 Is a Negative Regulator of the Epidermal Growth Factor Receptor Signal
|
---|---|
Published in |
Biological Chemistry, June 2005
|
DOI | 10.1515/bc.2001.200 |
Pubmed ID | |
Authors |
P O Hackel, M Gishizky, A Ullrich |
Abstract |
In contrast to signal generation and transmission, the mechanisms and molecules that negatively regulate receptor tyrosine kinase (RTK) signaling are poorly understood. Here we characterize Mig-6 as a novel negative feedback regulator of the epidermal growth factor receptor (EGFR) and potential tumor suppressor. Mig-6 was identified in a yeast two-hybrid screen with the kinase active domain of the EGFR as bait. Upon EGF stimulation Mig-6 binds to the EGFR involving a highly acidic region between amino acids 985-995. This interaction is kinase activity-dependent, but independent of tyrosine 992. Mig-6 overexpression results in reduced activation of the mitogenactivated protein kinase ERK2 in response to EGF, but not FGF or PDGF, stimulation and in enhanced receptor internalization without affecting the rate of degradation. The induction of Mig-6 mRNA expression in response to EGF, but not FGF, indicates the existence of a negative regulatory feedback loop. Consistent with these findings, a possible role as tumor suppressor is indicated by Mig-6-mediated inhibition of EGFR overexpression-induced transformation of Rati cells. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 4% |
Unknown | 27 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 29% |
Other | 3 | 11% |
Student > Doctoral Student | 3 | 11% |
Student > Bachelor | 3 | 11% |
Student > Ph. D. Student | 3 | 11% |
Other | 5 | 18% |
Unknown | 3 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 10 | 36% |
Agricultural and Biological Sciences | 6 | 21% |
Arts and Humanities | 2 | 7% |
Medicine and Dentistry | 2 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Other | 4 | 14% |
Unknown | 3 | 11% |